Biosym A/S

Public limited companyCVR 21774189IkastActive

Biosym A/S is a public limited company, based in Ikast, active in wholesale of pharmaceutical goods and nursing supplies, founded in 1999. Net profit rose 124% from 2024 to 2025, ending at DKK 8.5m. Equity grew to DKK 46.3m in 2025.

Follow
PDF reportCompare

Key figures · financial year 2025

Gross profitDKK 23.6m+45.4% vs. 2024
Net profitDKK 8.5m+123.8% vs. 2024
EquityDKK 46.3m+22.6% vs. 2024
Employees19latest month from CVR

What has changed

calculated from recorded figures and dates

Financials: 2025 against 2024

  • Gross profit rose 45% (2024 → 2025), to DKK 23.6m.
  • Net profit rose 124% (2024 → 2025), to DKK 8.5m.
  • Equity rose 23% (2024 → 2025), to DKK 46.3m.

Employees

  • 1 more employees than a year earlier: 19 (08/2026) against 18 (08/2025).

Management and owners, last 24 months

  • New in management: Kati Marika Rajala (chair of the board, 28/11/2024) and Elina Liisa Maarit Haavisto (board member, 27/03/2025).
  • Stepped down: Sebastian Nordman (board member, 27/03/2025) and Sami Oinas (chair of the board, 28/11/2024).

Calculated from the latest two annual reports in sequence and from registrations in CVR. A figure that is missing in either year gives no line, and we derive no figures.

Financial statements

Financial years 2020–2025 · amounts in DKK thousand

Equity and net profit

DKK 0DKK 10mDKK 20mDKK 30mDKK 40mDKK 50m202020212022202320242025
EquityNet profit
Financial figures for Biosym A/S
202020212022202320242025Change
Revenuenot statednot statednot statednot statednot statednot stated–
Gross profit17,95118,63512,99115,33516,19623,553+45.4%
Operating profit (EBIT)8,6629,5303,4085,4895,44611,430+109.9%
Profit before tax8,3679,1132,6734,5754,89310,938+123.5%
Net profit6,6777,1082,1104,1123,8118,530+123.8%
Total assets50,01555,31971,57357,82658,19772,550+24.7%
Equity20,64127,74929,85933,97037,78146,312+22.6%
Cash and cash equivalents8,5452363172,4347,3593,788−48.5%
Average number of employees1918181819190%

Source: annual reports filed with the Danish Business Authority (XBRL). Figures for the company (not the group); change is the latest year against the year before. “–” means the figure is not stated in the annual report. Revenue is not stated for 2020, 2021, 2022, 2023, 2024, 2025: smaller companies may omit it, and we do not derive it from other figures.

Download the figures as CSV · free with an account, amounts in whole DKK

DKK 0DKK 5mDKK 10mDKK 15mDKK 20mDKK 25m202020212022202320242025
Gross profitMedian, the industry (232 companies)

Signals from the financial statements

calculated from the 2025 figures
  • Profit for five years in a row

    Net result has been positive in 2021–2025.

    How is this calculated?

    Net result is positive in the five latest annual reports in a row.

The signals are rules applied to the figures in the annual reports. They are not an assessment or credit rating of the company. See Data and method.

Annual reports

6 financial years
Annual reports for Biosym A/S
Financial yearPeriodPublishedFigures forDocuments
202501/01/2025 – 31/12/202518/05/2026The companyPDF not statedXBRL
202401/01/2024 – 31/12/202427/05/2025The companyPDFXBRL
202301/01/2023 – 31/12/202305/06/2024The companyPDFXBRL
202201/01/2022 – 31/12/202225/05/2023The companyPDFXBRL
202101/01/2021 – 31/12/202130/06/2022The companyPDFXBRL
202001/01/2020 – 31/12/202001/07/2021The companyPDFXBRL

The figures from all the annual reports are shown on this page. The documents themselves (PDF and XBRL, the machine-readable edition) are downloaded with a Pro account: sign in or create a free account, and then choose Pro. XBRL is the edition the figures on the page are read from.

Employees

monthly figures from CVR
0510152009/2310/2311/2312/2301/2402/2403/2404/2405/2406/2407/2408/2409/2410/2411/2412/2401/2502/2503/2504/2505/2506/2507/2508/2509/2510/2511/2512/2501/2602/2603/2604/2605/2606/2607/2608/26
Employees

Position in the industry

232 companies in the database

Comparison with the other companies in wholesale of pharmaceutical goods and nursing supplies based on the latest financial year.

Gross profitDKK 23.6mNo. 87 of 232
Better than 63% of the companies in the industry
EquityDKK 46.3mNo. 46 of 232
Better than 81% of the companies in the industry
Number of employees19No. 78 of 232
Better than 67% of the companies in the industry

Industry median: gross profit DKK 11.2m, net profit DKK 1.8m, equity DKK 9.6m, 9 employees.

DKK 100kDKK 1.4mDKK 19.1mDKK 263.2mDKK 1.5bnHere
Distribution of gross profit for 225 companies in the industry (latest financial year, logarithmic scale). Amber bar: where this company sits.

Compared with similar companies

size, age and company form
Rank among similar companies
GroupGross profitEquity
Companies with fewer than 20 employees69,967 companies in the comparison
No. 1,186of 69,742
Better than 98%
No. 3,268of 69,964
Better than 95%
Same industry and fewer than 20 employees150 companies in the comparison
No. 18of 150
Better than 89%
No. 9of 150
Better than 95%
Companies that are between 15 and 29 years old24,910 companies in the comparison
No. 2,933of 24,791
Better than 88%
No. 2,469of 24,909
Better than 90%
All companies of type A/S18,025 companies in the comparison
No. 5,260of 17,786
Better than 70%
No. 3,759of 18,024
Better than 79%

The rank is calculated among companies in the database with a figure for the latest financial year, and is shown only for groups of at least ten companies.

Compare with the industry

Wholesale of pharmaceutical goods and nursing supplies
Gross profit
  1. Biosym A/SDKK 23.6m
  2. Ambu A/SDKK 3.6bn
  3. Stada Nordic ApSDKK 687m
Net profit
  1. Biosym A/SDKK 8.5m
  2. Ambu A/SDKK 609m
  3. Stada Nordic ApSDKK 54.6m
Equity
  1. Biosym A/SDKK 46.3m
  2. Ambu A/SDKK 6bn
  3. Stada Nordic ApSDKK 346.3m
Employees
  1. Biosym A/S19
  2. Ambu A/S619
  3. Stada Nordic ApS51

Latest financial year per company. Choose up to three companies from the largest in the industry.

Owners and group

from the Public Ownership Register
Owners
  • Oy Verman Ab100%
Biosym A/S

Management

4 active registrations

Executive management

Executive management at Biosym A/S
NameRoleAppointed
Sanne BiisgaardDirector31/07/2020

Board of directors

Board of directors at Biosym A/S
NameRoleAppointed
Janne VertanenBoard member01/07/2020
Kati Marika RajalaChair of the board28/11/2024
Elina Liisa Maarit HaavistoBoard member27/03/2025
Auditor
KPMG P/S
Founders
Kim Nielsen
Former management (10)
Former management at Biosym A/S
NameRoleAppointedResigned
Kim NielsenBoard member16/06/199906/05/2019
Kim NielsenDirector16/06/199931/07/2020
Bituin Guillermo NielsenBoard member16/06/199906/05/2019
Kurt NielsenBoard member16/06/199906/11/2008
Michelle Castillo KristensenBoard member06/11/200806/05/2019
Susanne GenetCEO26/03/201208/11/2012
Janne VertanenChair of the board06/05/201930/06/2020
Sebastian NordmanBoard member06/05/201927/03/2025
Ilona Odé-HaapiainenBoard member06/05/201901/07/2020
Sami OinasChair of the board01/07/202028/11/2024

Signing rule: Selskabet tegnes af bestyrelsesformanden alene, af direktøren og et bestyrelsesmedlem i forening eller af den samlede bestyrelse.

Address and production units

1 active production units

Lene Haus Vej 25
7430 Ikast

Ikast-Brande Municipality · Postcode 7430

Production units
Production unitAddressEmployeesP number
BIOSYM A/SLene Haus Vej 25, 7430 Ikast191005196387

Purpose

Selskabets formål er salg af kosttilskud. Selskabets produkter distribueres gennem webshops, helse- og skønhedsbutikker samt apoteker i hele Danmark og Nordeuropa.

The purpose is quoted from the register in Danish.

Changes year by year

41 registered events
20261 changeaccounts 1
  • Annual report for 2025 published
20253 changesaccounts 1 · management 2
  • Annual report for 2024 published
  • Elina Liisa Maarit Haavisto appointed board member
  • Sebastian Nordman stepped down as board member
20243 changesmanagement 2 · accounts 1
  • Kati Marika Rajala appointed chair of the board
  • Sami Oinas stepped down as chair of the board
  • Annual report for 2023 published
20231 changeaccounts 1
  • Annual report for 2022 published
20222 changesaccounts 1 · address 1
  • Annual report for 2021 published
  • Moved to Lene Haus Vej 25, 7430 Ikast
20211 changeaccounts 1
  • Annual report for 2020 published
20207 changesmanagement 6 · address 1
  • Sanne Biisgaard appointed director
  • Kim Nielsen stepped down as director
  • Sami Oinas appointed chair of the board
  • Janne Vertanen appointed board member
  • Ilona Odé-Haapiainen stepped down as board member
  • Janne Vertanen stepped down as chair of the board
  • Moved to Lene Haus Vej 25, 7430 Ikast
20198 changesmanagement 6 · ownership 2
  • Sebastian Nordman appointed board member
  • Janne Vertanen appointed chair of the board
  • Ilona Odé-Haapiainen appointed board member
  • Michelle Castillo Kristensen stepped down as board member
  • Bituin Guillermo Nielsen stepped down as board member
  • Kim Nielsen stepped down as board member
  • Oy Verman Ab registered as owner (100%)
  • Bituin Finans ApS is no longer registered as owner
20182 changesaddress 2
  • Moved to Lene Haus Vej 25, 7430 Ikast
  • Moved to Lene Haus Vej 25, 7430 Ikast
20151 changeaddress 1
  • Moved to Norgesgade 5, 7430 Ikast
20122 changesmanagement 2
  • Susanne Genet stepped down as ceo
  • Susanne Genet appointed ceo
20082 changesmanagement 2
  • Michelle Castillo Kristensen appointed board member
  • Kurt Nielsen stepped down as board member
20071 changeaddress 1
  • Moved to Skolegade 49, 7430 Ikast
20011 changeownership 1
  • Bituin Finans ApS registered as owner (100%)
19996 changescapital 1 · founded 1 · management 4
  • Share capital changed from 500,000 DKK to 900,000 DKK
  • Registered as BIOSYM A/S
  • Kim Nielsen appointed director
  • Kurt Nielsen appointed board member
  • Bituin Guillermo Nielsen appointed board member
  • Kim Nielsen appointed board member

Related companies

Same industry in Ikast-Brande

See all →

Same people in management

Largest in the industry

See all →

Source and updates

The information comes from the Danish Central Business Register (Danish Business Authority) and from annual reports filed with the Danish Business Authority. Last synchronised 24/10/2026. The company is protected against advertising; contact details are not shown, and the data must not be used for marketing.

View in CVRReport a correction